Author Akanksha is a Research Analyst at Verified Market Research, with expertise across Mining, Energy, Chemicals, and Transportation markets
certificate of analysis available on request Research Applications Suitable Laboratory Uses for FOXO4-DRI FOXO4-p53 protein-protein interaction disruption assays CO-IP, competitive binding, and proximity ligation studies Selective senescent cell apoptosis induction SA--gal, p16, p21, p53 marker-confirmed senescent populations p53 TAD2 binding, phospho-p53 (Ser15) nuclear exclusion, and mitochondrial translocation pathway studies BAX/BCL-2/Caspase-3 intrinsic apoptosis cascade investigations in senescent cell models SASP characterisation and suppression IL-6, IL-8, MMP, VEGF, CXCL2/3 secretome studies Tissue-specific senescence models fibroblasts, endothelial cells, Leydig cells, chondrocytes, keloid fibroblasts Vascular ageing pathway research endothelial senescence, aortic function, and ROS pathway studies Senescent cancer cell biology and drug resistance pathway research Comparative senolytic research FOXO4-DRI vs
2 adrenergic receptor activation
Peptide therapy is one tool in the toolbox-we help you understand where it fits for your goals
Competing interests The authors say that they have no commercial or financial ties that could be seen as a competing interests in the study we did
Learn more about the genO-hSA/hFcRn model #Pharmacokinetics #preclinicalmodels #genoway genOways Post Are NHPs the only option to assess the PK of therapeutics
